Coexistent COPD and ILD

Matthew D. Jankowich, Sharon Rounds

Source: Eur Respir Monogr 2015; 69: 109-120
Journal Issue: Controversies in COPD
Disease area: Interstitial lung diseases

Full text journal articleCongress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Matthew D. Jankowich, Sharon Rounds. Coexistent COPD and ILD. Eur Respir Monogr 2015; 69: 109-120

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Unclassifiable ILD
Source: ERS Courses: Interstitial Lung Diseases
Year: 2019


Unclassifiable ILD
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2019


Prevelance of anemia in patients with COPD
Source: Annual Congress 2006 - COPD comorbidity
Year: 2006


ILD
Source: Virtual Congress 2020 – Impact in children and in adults with premorbid respiratory disease (acute and long-term)
Year: 2020


Chronic obstructive pulmonary disease (COPD) patients with bronchiectasis: clinical features?
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018


Exacerbation of COPD
Source: Annual Congress 2008 - Exacerbations of chronic respiratory disease – state of the art
Year: 2008


Non-CF bronchiectasis, an obstructive disease. Similarities with COPD?
Source: Eur Respir J 2005; 26: Suppl. 49, 59s
Year: 2005

Systemic and pulmonary inflammation in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Pathophysiology of COPD
Year: 2008


Clinical features of COPD in patients with chronic pulmonary aspergillosis
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009


Prevalence of bronchiectasis in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 60s
Year: 2006

Bronchiectasis impact outcomes in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


Comorbidities in patients with the combined pulmonary fibrosis and emphysema syndrome (CPFE)
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015

COPD and other pulmonary diseases
Source: Eur Respir Monogr 2015; 67: 161-178
Year: 2015


Potential biomarkers in patients with chronic obstructive pulmonary disease (COPD)
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020


Minimal bronchiectasis in chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009

The impact of using different symptom-based exacerbation algorithms in patients with COPD
Source: Eur Respir J 2011; 37: 1260-1268
Year: 2011



Prevalence of metabolic syndrome in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016


Benefits of pulmonary rehabilitation (PR) in patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) having the same dyspnoea severity
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018

Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) and COPD concomitant with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 521s
Year: 2004

Impact of comorbidities on chronic obstructive pulmonary disease (COPD) exacerbations in Singapore
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015